Is there an Indian version of Dacomitinib? Is the Indian version as effective as the original drug?
The original drug of dacomitinib has been launched in China and is included in medical insurance. Patients can enjoy medical insurance reimbursement when purchasing it in China, and the price is relatively high. According to market conditions, the original drug price of dacomitinib is approximately 5,680 yuan per box (15mg*30 tablets). After being reimbursed through medical insurance, the actual burden of the patient will be greatly reduced. Usually the cost paid by the patient is about 1,300 yuan. In India, due to the competitiveness of the Indian version of generic drugs, the price will be significantly lower than the original drug, providing patients with a more economical choice.
Compared with brand-name drugs, generic drugs have significant price advantages, especially in the pharmaceutical markets of developing countries, where generic drugs provide an affordable option. Although generic drugs are less expensive, because their active ingredients are basically the same as those of the original drugs, they usually do not have a significant impact on the patient's therapeutic effect. However, patients are advised to consult a doctor or pharmacist before purchasing and using any medication to ensure the suitability and safety of the medication.
Reference: https://www.pfizer.com/products/product-detail/vizimpro
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)